(P<0.001) were bearing significantly higher numbers of susceptible loci for PD. There are four genes which associated with susceptibility to PD on 1q31-q32 (SLC45A3, NUCKS1, SLC41A1, and PM20D1/ PARK16). There are three genes which associated with susceptibility to PD on 17q21-q23 (PLEKHM1, MAPT, and MED13).
There were 789 studies concerning the associations between 809 genes (2907 polymorphisms) and susceptibility to MS. Table 2 shows the genes with their genetic polymorphisms associated with risk of MS in at least one ethnic group. There are 44 loci associated with MS risk. Statistical analysis revealed that the MS susceptible loci distributed non-randomly on human chromosomes. Human chromosome segments 1p22, 5p13, 17q12-21.2, 19p13, and 19q13 (P<0.001) were bearing significantly higher numbers of susceptible loci for MS. There are four genes which associated with MS risk on 5p13 (IL7R, PTGER4, C7, and HEATR7B2). There are three genes which associated with susceptibility to MS on each chromosomal segments of 1p22 (EVI5, RPL5, and FAM69A), 17q12-21.2 (CCL8, CCL1, and STAT), 19p13 (VAV1, TYK2, and IFI30) and 19q13 (TGFB1, APOE, and LILRA3).
Already the non-random distributions of polymorphic loci associated with both breast cancer (Saify and Saadat, 2012) and schizophrenia (Saadat, 2013) , were reported. A mass screening test might be designed using genes located on above mentioned chromosome segments for diagnosis of PD and MS. It is suggested that using simultaneously polymorphisms of the genes located on the above mentioned chromosome segment can increase the sensitivity and specificity of the mass screening test for detecting high risk individuals for developing Parkinson's disease and multiple sclerosis. 
